Vestcor Inc Grows Position in Tenet Healthcare Corporation $THC

Vestcor Inc lifted its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 132.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 13,986 shares of the company’s stock after buying an additional 7,969 shares during the quarter. Vestcor Inc’s holdings in Tenet Healthcare were worth $2,840,000 as of its most recent filing with the SEC.

Other hedge funds also recently added to or reduced their stakes in the company. WINTON GROUP Ltd bought a new position in Tenet Healthcare during the 3rd quarter worth $7,748,000. Schroder Investment Management Group increased its position in shares of Tenet Healthcare by 165.8% during the 3rd quarter. Schroder Investment Management Group now owns 40,497 shares of the company’s stock valued at $8,148,000 after purchasing an additional 25,262 shares during the period. Private Advisor Group LLC boosted its holdings in Tenet Healthcare by 379.9% during the third quarter. Private Advisor Group LLC now owns 5,884 shares of the company’s stock worth $1,195,000 after buying an additional 4,658 shares in the last quarter. Orion Porfolio Solutions LLC grew its holdings in shares of Tenet Healthcare by 62.3% in the 3rd quarter. Orion Porfolio Solutions LLC now owns 2,514 shares of the company’s stock worth $510,000 after acquiring an additional 965 shares during the last quarter. Finally, Integrated Quantitative Investments LLC acquired a new stake in shares of Tenet Healthcare during the third quarter valued at approximately $594,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. UBS Group raised their price target on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Wells Fargo & Company reissued an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a research report on Monday, February 16th. Royal Bank Of Canada raised their price target on shares of Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a research note on Thursday, February 12th. Finally, Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $247.67.

Tenet Healthcare Stock Down 1.4%

NYSE:THC opened at $237.30 on Wednesday. The stock’s fifty day simple moving average is $211.66 and its 200-day simple moving average is $203.29. The firm has a market capitalization of $20.64 billion, a P/E ratio of 15.32, a P/E/G ratio of 1.19 and a beta of 1.39. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $247.21. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. During the same period in the prior year, the business earned $3.44 EPS. Tenet Healthcare’s revenue for the quarter was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Insider Buying and Selling

In other news, EVP Thomas W. Arnst sold 24,000 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the transaction, the executive vice president directly owned 8,012 shares in the company, valued at approximately $1,875,128.48. The trade was a 74.97% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 42,195 shares of company stock valued at $9,823,406. 0.81% of the stock is owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.